Myeloid Metaplasia: Characteristics and Features
Myeloid metaplasia results in extramedullary hematopoiesis, which is the formation of bone marrow elements outside of the medullary cavity. 1, 2
Key Characteristics of Myeloid Metaplasia
- Myeloid metaplasia is characterized by extramedullary hematopoiesis, most commonly occurring in the spleen and liver 3
- It is typically associated with significant splenomegaly, not rarely associated with it 4
- It affects predominantly older adults with a median age at diagnosis of 60 years, with more than 90% of patients diagnosed after age 40 years (not young females) 4
- It is characterized by increased bone marrow megakaryocytes, which are atypical and hyperplastic 5
Pathophysiology
Myeloid metaplasia involves two pathogenetic processes:
The disease results in extramedullary hematopoiesis in various organs when bone marrow function is compromised 2, 3
Clinical Manifestations
- Massive splenomegaly is a hallmark feature 4
- Progressive anemia is common and contributes to morbidity 4
- Constitutional symptoms are often profound 4
- Extramedullary hematopoiesis can occur in various organs beyond the spleen and liver, including the lungs and pleura in some cases 3
Diagnostic Features
- Diagnosis is confirmed by bone marrow examination after ruling out other causes of myelofibrosis 4
- The presence of megakaryocytes admixed with other hematopoietic elements in extramedullary sites is a diagnostic feature 2
- Bone marrow typically shows substantial fibrosis 5
Prognosis and Treatment
- Median survival is approximately 5 years 4
- Poor prognostic factors include anemia (hemoglobin <10 g/dl), leukopenia or leukocytosis, circulating blasts, and hypercatabolic symptoms 4
- Conventional treatment is palliative and includes management of anemia with androgens, corticosteroids, or erythropoietin 4
- Symptomatic splenomegaly may require cytoreductive therapy or splenectomy 4
In summary, myeloid metaplasia is characterized by extramedullary hematopoiesis with increased and atypical bone marrow megakaryocytes. It predominantly affects older adults rather than young females and is typically associated with significant splenomegaly.